FemPulse Receives FDA IDE Approval for the Pivotal Clinical Trial of its Wearable Bioelectronic Device for Overactive Bladder in Women
FemPulse™ announced today Investigational Device Exemption (IDE) approval from the U.S. Food and Drug Administration (FDA) to begin its EVANESCE II pivotal clinical trial in female patients suffering ...
Hosted on MSN18h
EndoQuest wins FDA IDE to commence robot trial in colorectal indication
EndoQuest plans to test its technology on an estimated 50 participants enrolled across five sites in the US. The company’s ...
MassDevice20h
FemPulse wins FDA IDE for for overactive bladder neuromod
FemPulse announced today that it received FDA investigational device exemption (IDE) approval for its overactive bladder (OAB ...
Endovascular Today21h
RapidPulse Receives IDE Approval for Pivotal Study of Its Cyclic Aspiration System for Ischemic Stroke
RapidPulse, Inc. announced FDA approval of an investigational device exemption (IDE) for the company to study the RapidPulse c ...
Endovascular Today2d
Artivion Granted FDA Humanitarian Device Exemption for AMDS Hybrid Prosthesis
Artivion, Inc. announced that the FDA has granted a humanitarian device exemption (HDE) for use of the of the AMDS hybrid ...
US FDA Grants Investigational Device Exemption (IDE) to EndoQuest™ Robotics for Its Flexible Robotic System
EndoQuest will commence its PARADIGM clinical trial for endoluminal robotic colorectal surgery at five leading US hospitals ...
MassDevice21h
EndoQuest wins FDA IDE to study surgical robot in colorectal surgery
EndoQuest Robotics announced today that it received FDA investigational device exemption (IDE) for a study of its surgical ...
Morningstar17d
RTI Surgical Announces First Patient Enrolled in Investigational Device Exemption (IDE) for Cortiva® Allograft Dermis in Breast Reconstruction
This Investigational Device Exemption study is designed to confirm the safety and effectiveness of Cortiva® Allograft Dermis (ADM) in implant-based breast reconstruction. Cortiva® ADM ...
stocknews16d
Top 3 Dividend Aristocrats to Add to Your Portfolio
Dividend Aristocrats offer stability, reliable income, and risk mitigation, with consistent dividend growth helping to combat ...
GlobalData on MSN15d
Neuralink to launch feasibility trial with implant coupled to robotic arm
US-based Neuralink has received approval to launch a new feasibility trial studying its brain implant linked with an ...
Yahoo Finance28d
EndoQuest™ Robotics Submits Investigational Device Exemption (IDE) Application for Its Flexible Robotic System
has submitted an Investigational Device Exemption (IDE) application for its pivotal colorectal clinical study. EndoQuest’s mission is to transform surgical outcomes for minimally invasive ...